Table 2.
Test
|
Normal values
|
Wilson disease
|
False negative
|
False positive
|
Ceruloplasmin | 0.2-0.4 g/L | < 0.2 g/L | Increased levels: | Low levels: |
Hepatic inflammation | Malabsorption | |||
Malnutrition | ||||
Estrogen | Aceruloplasminemia | |||
Pregnancy | Menkes’ disease | |||
Infection | Terminal liver disease | |||
Children | Nephropathy with renal protein loss | |||
Overestimation by immunological assay | Excess zinc ingestion | |||
Healthy heterozygotes WD | ||||
Non ceruloplasmin bound copper | < 0.3 μg/dL | > 10 μg/dL | Overestimation of ceruloplasmin by immunological assay | Increased levels: |
Cholestatic syndromes | ||||
Acute liver failure | ||||
Copper intoxication | ||||
Urinary copper excretion | < 0.6 μmol/24 h; < 40 μg/24 h | > 1.6 μmol/24 h; > 100 μg/24 h | Incomplete collection; Children | Increased levels: |
Cholestatic syndromes | ||||
Autoimmune hepatitis | ||||
Chronic active liver disease or hepatocellular necrosis | ||||
Healthy heterozygotes WD | ||||
Liver biopsy | < 50 μg/g; < 0.8 μmol/g | > 250 μg/g; > 4 μmol/g | Uneven copper distribution | Increased levels: |
Cholestatic syndromes | ||||
Idiopathic copper toxicosis disorders | ||||
Kayser Fleischer rings | Absence | Present: Neurological WD | Primary biliary cholangitis | |
Absence: | ||||
50% hepatic WD | ||||
Asymptomatic WD |
WD: Wilson’s disease.